Gumiton, Princess D.

HRN: 28-29-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFUROXIME 750MG (VIAL)
12/16/2025
12/23/2025
IV
670mg
Q8
UTI, URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary TractURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: